This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK ...

NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period ...

Cruz announces that investors with losses related to GSK plc. ("GSK" or the "Company") (NYSE: GSK) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO ...

GSK Price Performance Shares of NYSE:GSK opened at $39.44 on Friday. GSK plc has a fifty-two week low of $31.72 and a fifty-two week high of $45.93. The business has a 50-day moving average of $36 ...

notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE:GSK) and certain of its officers. Class Definition This lawsuit seeks to recover ...

LOS ANGELES, Feb. 25, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against GSK plc.

notifies investors that a class action lawsuit has been filed against GSK plc (“GSK” or “the Company”) (NYSE: GSK) and certain of its officers. Class Definition This lawsuit seeks to ...